New York City, NY -- (SBWIRE) -- 10/30/2013 -- StockMarketIntel.com issues a special report on the following stocks: ARRIS GROUP DL-,01 (NASDAQ:ARRS), Medical Marijuana Inc (OTCMKTS:MJNA), Nuvilex Inc (OTCMKTS:NVLX), Globalstar, Inc. (OTCMKTS:GSAT)
ARRIS GROUP DL-,01 (NASDAQ:ARRS) added 0.36%, trading on 1.35 million shares, to end the trade at $16.59. The stock changed hands in a range of $16.48 to $16.64, bringing its market capitalization to about $2.28 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $13.48 and was moved to the maximum level of $17.98.
What was the Moving Force behind ARRS on Bullish Run? Read This Research Report
Medical Marijuana Inc (OTCMKTS:MJNA) declined -3.66%, to complete the trading session at $0.142, with a total volume of 2.94 million shares. The stock, on average, trades on a volume of 6.63 million shares. It floated in a range of $0.14 to $0.15 during the last trading session, with a beta value of 4.92. Its market capitalization now moved to about $134.51 million. In the past 52 weeks, the share price has not declined below $0.07 and above $0.50. Medical Marijuana Inc. (MJNA) is the publicly held company vested in the medical marijuana and industrial hemp markets. It is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries. These products range from patented and based cannabinoid products, to whole plant or isolated high value extracts specifically manufactured and formulated for the pharmaceutical, nutraceutical and cosmeceutical industries.
Will MJNA Reach the Bottom after Yesterday’s Correction? Find Out Here
Nuvilex Inc (OTCMKTS:NVLX) declined -1.48% and was in a range of $0.11-$0.12 before closing at $0.113. The share price hit its 52-week low of $0.02 and $0.22 was the best price. The stock completed the day with a total volume of 1.40 million shares, versus an average volume of 1.64 million shares. Nuvilex, Inc. operates independently and through wholly owned subsidiaries. The Company is a biotechnology and life technology company with a specialty in living-cell encapsulation. It is focused on preparations for a new pancreatic cancer clinical trial through live-cell encapsulation of chemotherapeutic-converting cells. It has created the hardware and operating platform to envelop or encapsulate its own or other company's software products, or cells. These cells are then packaged in its live cell encapsulation operating system.
Has NVLX Found The Bottom and Ready To Move Up? Find Out Here
Albemarle Corporation (NYSE:ALB) declined -0.42% yesterday, bringing its market capitalization around $5.44 billion. The total number of shares that changed hands during the session was 564,409 shares, as compared to average trading volume of 792,520 shares. The share price, after opening at $67.10, made a high of $67.43 and hovered above $66.25 to end the day at $66.84. Albemarle Corporation (Albemarle) is a developer, manufacturer and marketer of specialty chemicals, which meet customer needs across a range of end markets, including the petroleum refining, consumer electronics, plastics/packaging, construction, automotive, lubricants, pharmaceuticals, crop protection, food-safety and custom chemistry services markets.
Has ALB Found The Bottom And Ready To Gain Momentum? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)